Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Obesity 2Urologic Neoplasms 1Stomach Neoplasms 1Smoking 1Sarcopenia 1Risk Reduction Behavior 1Postoperative Complications 1Patient Preference 1Overweight 1Motor Activity 1Malnutrition 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Alcohol Drinking 1

Interventions

Oxaliplatin 270Bevacizumab 260Fluorouracil 249Irinotecan 240Leucovorin 218Capecitabine 196Cetuximab 161Colonoscopy 74Folfox protocol 70Panitumumab 64regorafenib 62Drug Therapy 52Radiotherapy 50HMPL-013 50Blood Specimen Collection 45trifluridine tipiracil drug combination 43pembrolizumab 41Surveys and Questionnaires 35Standard of Care 35Nivolumab 34Neoadjuvant Therapy 34Surgical Procedures, Operative 33Magnetic Resonance Spectroscopy 31IFL protocol 27Trifluridine 26Interviews as Topic 26Celecoxib 26XELOX 25Early Intervention, Educational 24Specimen Handling 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Colorectal Neoplasms × Adiposity × Clear all
NCT06606912 2024-09-23

Predictive Effect of Abdominal Fat and Muscle Area Calculated Based on Abdominal CT on Gastric Cancer Patients

First Affiliated Hospital of Chongqing Medical University

Active not recruiting
4,000 enrolled
GastrointestinalOther

Gastrointestinal Neoplasms, Obesity, Stomach Neoplasms, Colorectal Neoplasms, Overweight, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡